Publicaciones científicas sobre los diagnósticos no invasivos de BioPredictive
Estudios revisados por pares que validan los diagnósticos por análisis de sangre de BioPredictive para enfermedades hepáticas — desde cohortes de desarrollo pioneras hasta metaanálisis a largo plazo.
331/435
Coincidencias para
“non-invasive markers of liver fibrosis and cirrhosis”
-
Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.
### Aim To assess the performance of several non-invasive markers and of…
-
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
…that performance of non-invasive markers for liver fibrosis in hepatitis C…
-
A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Review
…on non-invasive methods currently available for predicting liver fibrosis in HCV…
-
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.
…non-invasive fibrosis biomarkers may be influenced by aetiology of chronic liver…
-
Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. Review
…non-invasive fibrosis markers have been suggested as alternatives to liver biopsy…
-
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
…diagnostic performance of non-invasive markers of liver fibrosis by combining them…
-
The Diagnostic Value of FibroTest and Hepascore as Non-Invasive Markers of Liver Fibrosis in Primary Sclerosing Cholangitis (PSC).
…of two non-invasive, validated, and patented markers of liver fibrosis, the…
-
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
### Background & Aims Non-invasive assessment of liver fibrosis is a challenging area…
-
Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. Review
…and differentiating liver fibrosis. Finally, studies have shown that non-invasive methods…
-
Concordance of non-invasive serology-based scoring indices and transient elastography for liver fibrosis and cirrhosis in chronic hepatitis C.
…markers for significant liver fibrosis (METAVIR ≥F2), advanced liver fibrosis (≥F3) and…
-
Hepatitis B: are non-invasive markers of liver fibrosis reliable? Review
…of fibrosis, has been challenged in the past decade by non-invasive…
-
Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. Review
…of liver biopsy (invasive procedure, sampling errors, inter-observer variability and nondynamic…
-
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Key publication
-
Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. Review
…Multiple non-invasive methods of liver fibrosis assessment have been developed, but…
-
Liver fibrosis markers in alcoholic liver disease. Review
…Staging of liver fibrosis is essential to define prognosis and management of…
-
Non-invasive markers for hepatic fibrosis. Review
…The rate of adoption of non-invasive diagnostic tests for liver fibrosis…
-
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis.
…accuracy for the non-invasive staging of liver fibrosis. Serum tests are…
-
The non-invasive assessment of hepatic fibrosis. Review
…the necessity of non-invasive tools to detect and grade liver fibrosis.
-
Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter study.
…Utility of non-invasive markers of liver fibrosis has been proved in…
-
Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Review
…The detection and quantification of liver fibrosis is a key factor for…
-
Noninvasive assessment of portal hypertension in patients with cirrhosis. Review
…and mainly involve the detection of hepatic fibrosis by serum markers and…
-
Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
…non-invasive tests increased the accuracy for detection of liver fibrosis to…
-
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.
…of antiviral treatment on non-invasive serological markers of liver fibrosis in…
-
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
…performance of seven non-invasive tests (NITs) of liver fibrosis and to…
-
Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Review
…Non-invasive biological tests have also been evaluated to assess liver fibrosis…
-
The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.
…accuracy of the non-invasive diagnosis of liver fibrosis and, consequently, markedly…
-
Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.
…most accurate non-invasive biochemical scores for liver fibrosis assessment in HIV…
-
Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.
### Objective And Methods We assessed the reliability of non-invasive biological scoring…
-
Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.
…cause of chronic hepatitis and hepatic fibrosis. Liver biopsy, because of its…
-
An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis.
…of non-invasive testing strategies in the diagnosis of significant liver fibrosis…
-
Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.
…and FibroTest (FT) are frequently used as non-invasive alternatives for fibrosis…
-
Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study.
…value of FibroTest, a non-invasive marker of liver fibrosis, for the…
-
Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
### Background Non-invasive liver fibrosis scores such as Hepascore (HS) have been…
-
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review.
…of liver biopsy. ### Data Extraction Investigators abstracted and checked study details and…
-
Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.
…of nine non-invasive serum biomarkers with liver biopsies to predict liver…
-
Current Possibilities to Assess the Degree of Liver Fibrosis in Patients with Haemophilia Infected with HCV--Review. Review
…and minimally invasive assessment of liver disease progression and classification of the…
-
Clinical applicability of non-invasive markers for liver fibrosis in chronic hepatitis C (Letter)
-
Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
…most accurate non-invasive method for early detection of cirrhosis in CHC…
-
Liver biopsy: the best standard...when everything else fails.
-
Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.
…values. ### Methods LSM and liver fibrosis biochemical markers were performed on 225…
-
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
…non-invasive liver fibrosis biomarkers for the prediction of significant liver fibrosis.
-
Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Review
…of non-invasive tests of fibrosis allows accurate diagnosis of cirrhosis and…
-
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?
-
Relationship between the Fibrotest and portal hypertension in patients with liver disease.
…and the presence and degree of PHT in patients with liver disease…
-
Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients.
…accuracy of non-invasive methods for the assessment of liver fibrosis stage.
-
Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients.
…of this study was to evaluate liver fibrosis using non-invasive methods…
-
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
…of fibrosis progression in chronic liver diseases and better identification of risk…
-
Systematic review: Investigating the prognostic performance of four non-invasive tests in alcohol-related liver disease.
…and liver fibrosis stage is the best mortality predictor. Non-invasive tests…
-
A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
…and improves the accuracy of the non-invasive diagnosis of liver fibrosis…
-
Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.
…strength of concordance between non-invasive estimates of liver fibrosis for the…
-
Non-invasive diagnosis and follow-up of portal hypertension.
…chronic liver disease (cACLD) describes the spectrum of advanced fibrosis/cirrhosis in…
-
Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.
…of liver stiffness, non-invasive tests of liver fibrosis, and liver biopsy…
-
Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
…hepatic fibrosis is prognostic of liver morbidity and mortality in non-alcoholic…
-
Noninvasive Assessment of Liver Fibrosis.
…and progression of liver fibrosis with the risk of developing cirrhosis. Liver…
-
Noninvasive evaluation of NAFLD. Review
…of NASH. Ultrasonography-based transient elastography can exclude advanced fibrosis and cirrhosis…
-
Non-invasive diagnosis of hepatitis B virus-related cirrhosis. Review
…assessment of liver fibrosis. However, the method is invasive, and is associated…
-
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Key publication
…markers of fibrosis and activity for use as a non-invasive alternative…
-
Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.
…significant fibrosis (F2 and F3) on liver biopsy. ### Conclusion Non-invasive tools…
-
Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. Review
…NAFLD', 'non invasive method and NAFLD', 'transient elastography' and 'liver fibrosis'. The…
-
Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
…using non-invasive biomarkers without liver biopsy. One hundred and thirty-two…
-
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
…Hepascore® perform best and similarly for diagnosis of significant fibrosis and cirrhosis.
-
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. Review
…higher risk of non-liver- and liver-related morbidity and mortality. More…
-
Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience. Key publication Review
-
Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
…of the Fibroscan and Fibrotest to detect significant MTX-induced liver fibrosis…
-
Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
…system that allows quantification of liver fibrosis and inflammation. This test has…
-
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.
…and non-invasive markers. They exerted an impact on immunosuppressive and antiviral…
-
Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.
…expensive and carries risks of complications. FibroTest is a non-invasive biomarker…
-
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.
…liver disease. Noninvasive tests of steatosis, nonalcoholic steatohepatitis (NASH), and fibrosis have…
-
FibroMAX: towards a new universal biomarker of liver disease? Review
…of chronic liver diseases: FibroTest (BioPredictive) for the quantitative assessment of fibrosis…
-
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
### Background & Aims The diagnostic accuracy of non-invasive liver fibrosis tests that…
-
Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C.
…to improve evaluation of fibrosis by non-invasive methods. Fifty-seven hepatitis…
-
Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
…Aims To assess Fibroscan for non-invasive diagnosis of asymptomatic liver fibrosis…
-
Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.
### Background Liver fibrosis, now assessed by liver biopsy or using non-invasive…
-
Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.
…liver biopsy and aspartate aminotransferase-to-platelet ratio (APRI), fibrosis index-4…
-
Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
…Diagnostic accuracies for significant fibrosis (METAVIR F ≥ 2) and cirrhosis (F4) were…
-
Altered serum N-glycomics in chronic hepatitis B patients.
…and is a non-invasive blood test for the diagnosis of liver…
-
Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection. Key publication
…and to compare FT-AT analysis with liver histology. A total of…
-
Appropriate evidence-based data overviews demonstrate the diagnostic and prognostic performances of FibroTest in patients with chronic hepatitis C.
-
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.
…non-invasive index of biochemical markers for the prediction of fibrosis in…
-
Prevalence of liver fibrosis and cirrhosis in 699 Moroccan patients with chronic hepatitis C.
…prevalence of liver fibrosis and cirrhosis using a non-invasive blood test…
-
Changes of non-invasive markers and FibroScan values during HCV treatment.
The recent advent of non-invasive methods for assessment of fibrosis allows…
-
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
…of fibrosis by morphometry and changes in blood markers of fibrosis. ### Results…
-
Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.
…liver disease, with the use of non-invasive markers of liver fibrosis…
-
Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience.
…advanced fibrosis and <10% for cirrhosis) and between ActiTest and LB. Specificity…
-
Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
…008] and the stage of fibrosis F0, F1, F2 [OR =3. 35…
-
Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
Non-invasive biomarkers have gained popularity for estimating fibrosis stage. In our…
-
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. Key publication
…of non-invasive markers of fibrosis, validated in chronic viral hepatitis and…
-
First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy.
-
Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C.
…in which fibrosis was evaluated by liver biopsy (Metavir) and tests: Fibrometer…
-
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program.
…FT), a validated non-invasive marker of fibrosis in treatment-naive patients…
-
Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
### Background/Aims Non-invasive markers of liver fibrosis have recently been developed…
-
Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.
…of fibrosis progression in chronic liver disease relies upon non-invasive tools…
-
Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.
### Background FibroTest has been validated for the diagnosis of liver fibrosis in…
-
Noninvasive Assessment of Liver Fibrosis. Key publication Review
-
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.
…of liver biopsies. A third algorithm identified significant fibrosis and cirrhosis simultaneously…
-
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
…prevalence of each fibrosis stage defining advanced and non-advanced fibrosis. ### Results…
-
Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
…for assessing liver fibrosis and no reliable non-invasive diagnostic approach is…
-
Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Key publication Review
…aspects of the interpretation of non-invasive biomarkers in liver fibrosis. A…
-
Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis.
…non-invasive multiparametric tests for staging and grading of liver fibrosis. ### Methods…
-
The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.
…of fibrosis and/or activity, and decreases the need for a liver…
-
Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.
…of FibroTest and Fibroscan for the diagnosis of advanced fibrosis and cirrhosis…
-
FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.
### Background Two widely used biomarkers of fibrosis, FibroTest and liver stiffness measurement…
-
Meta-analyses of FibroTest diagnostic value in chronic liver disease. Key publication Meta Analysis
### Background FibroTest (FT) is a biomarker of liver fibrosis initially validated in…
-
Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.
…Non-invasive methods for the diagnosis of liver fibrosis, such as transient…
-
Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.
### Background And Aims Diagnostic values of FibroTest (FT) for hepatic fibrosis have…
-
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
-
Guidelines for the diagnosis of uncomplicated cirrhosis.
-
FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Key publication Meta Analysis
…and non-alcoholic fatty liver disease (NAFLD). The primary aim of the…
-
Biomarkers of liver fibrosis. Review
…advantages and the limits of the available biomarkers of liver fibrosis. Among…
-
Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children.
…prevalence of signs of liver affection, and analyse the influence of the…
-
The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.
…and observance of the technical recommendations for the assays of biochemical markers…
-
Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.
…advanced fibrosis, cirrhosis, and liver cancer. We examined the efficacy of a…
-
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.
…awareness of liver disease and both the HCV campaign and DAA availability…
-
Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.
…a non-invasive tool used in the evaluation of liver fibrosis in…
-
The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B.
…a simple and inexpensive biomarker to delineate liver fibrosis in chronic hepatitis…
-
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
…fibrosis stage and surrogate noninvasive markers of fibrosis (APRI, FORNS, FibroTest and…
-
Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. Meta Analysis
…and a control group. Meta-analysis of the percentage of fibrosis progression…
-
Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B.
…and every 6-12 months. From data on non-invasive liver fibrosis…
-
Assessment of liver fibrosis: noninvasive means.
…advantages and the limits of the available biomarkers of liver fibrosis. Among…
-
Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
…of four non-invasive tests for liver fibrosis [the Enhanced Liver Fibrosis…
-
Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection. Meta Analysis
…The prevalence of significant fibrosis and cirrhosis were 51% and 16%, respectively…
-
The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test.
…of liver diseases was assayed by means of non-invasive biomarkers: fibrosis…
-
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Key publication
### Background Blood tests of liver injury are less well validated in non…
-
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).
### Background FibroTest and elastography have been validated as biomarkers of liver fibrosis…
-
Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus. Key publication
…Similar impacts of ADV on liver fibrosis and activity were observed both…
-
Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.
…The risk of underestimating significant fibrosis and cirrhosis is however greater in…
-
FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted.
-
FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Meta Analysis
…of significant fibrosis and cirrhosis in the study populations. For cirrhosis, the…
-
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. Meta Analysis
…performance of non-invasive markers of fibrosis (FibroTest), steatosis (SteatoTest) and steato…
-
Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia.
…CONCLUSIONS The prevalence of fibrosis, steatosis and NASH in hyperlipidaemic patients appears…
-
Stage of liver fibrosis in patients with congenital bleeding disorders and infected with hepatitis C virus.
…fibrosis assessment, and to analyze the influence of risk factors on liver…
-
Noninvasive diagnosis in alcohol-related liver disease.
…Among the noninvasive surrogate markers and techniques used to detect liver fibrosis…
-
Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis.
…non-invasive, ultrasound-based method for the evaluation of liver fibrosis and…
-
The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests".
-
Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters? Review
…non-null rate of false negative for the diagnosis of liver cirrhosis…
-
Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.
…found between liver stiffness and portal and/or sinusoidal fibrosis. In patients…
-
FibroTest (FT) has similar accuracy for cirrhosis in 'intention-to-diagnose' which is superior to transient elastography (TE) in chronic hepatitis B.
-
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Meta Analysis
### Background ActiTest (AT) is a biomarker of liver necro-inflammatory histological activity…
-
Implementing non-invasive markers for liver fibrosis in clinical practice.
-
The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy. Meta Analysis
…for identification of HBV-related significant fibrosis and cirrhosis. FIB-4 has…
-
Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography.
…need of non-invasive validated methods to estimate liver fibrosis. ### Aim To…
-
Diagnostic accuracy of the Coopscore© to predict liver fibrosis in human immunodeficiency virus/hepatitis B virus co-infection.
Background Non-invasive methods for assessing liver fibrosis are increasingly used as…
-
Reproducibility of blood tests of liver fibrosis in clinical practice.
…reproducibility of blood test for liver fibrosis: FibroMeter, Fibrotest, APRI and their…
-
Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests.
…cirrhosis. ### Conclusion The detection rate and PPV for cirrhosis using fibrosis scales…
-
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.
…For F2-4, FS (n = 2055) had sensitivity and specificity of 0…
-
Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C.
…of detailed fibrosis classifications available for non-invasive tests and liver biopsy…
-
Diagnostic algorithms for liver fibrosis in hepatitis C: are they ready to avoid liver biopsy?
-
Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.
…Serum HCV RNA and non-invasive markers of fibrosis (FibroTest) were tested…
-
Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.
…Non invasive Liver FibroScan and Fibro-Test were reliable methods to assess…
-
Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastography.
…to evaluate dynamic changes of liver fibrosis and steatosis within 12 mo…
-
Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics.
…markers of liver fibrosis: APRI, GAPRI, Forns, FIB-4, Age-Platelet, and…
-
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
…of non-invasive serum biomarkers, separately and in combinations, on liver fibrosis…
-
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.
…In conclusion, FibroTest and LSM were the most validated biomarkers of fibrosis…
-
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.
…use of the biochemical markers of liver fibrosis (FibroTest) and necrosis (ActiTest…
-
Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy.
…Association between Fibroscan™ and Coopscore© might avoid 68% of liver biopsies for…
-
Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn's disease: correlation of transient elastography and laboratory-based markers.
…Correlation of inflammatory markers and noninvasive liver fibrosis tests, respectively, was generally…
-
Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.
…liver fibrosis amongst patients hospitalized for their diabetes, using non-invasive methods…
-
Editorial: FibroTest to predict liver-related mortality in NAFLD. Should this change the diagnostic algorithm in NAFLD?
-
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. Key publication
…The use of FibroTest (FT) and ActiTest (AT), biomarkers of fibrosis and…
-
Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.
…Elastometric thresholds were identified for significant fibrosis and cirrhosis. Combined use of…
-
Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. Key publication
### Background The efficiency of transient elastography for the assessment of liver fibrosis…
-
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.
…of fibrosis 10years later, a disappointing 5% decrease in cirrhosis cases, and…
-
Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".
…of fibrosis, comparisons of APRI with other non-invasive tests, and estimates…
-
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease.
-
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
…TPP) of blood tests of liver fibrosis. ### Methods Three hundred and fifty…
-
Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Meta Analysis
…the diagnosis of advanced fibrosis and 86 for cirrhosis. In All-CB…
-
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Key publication
…simple and non-invasive quantitative estimate of liver steatosis and may reduce…
-
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. Key publication
…and non-invasive quantitative estimate of alcoholic hepatitis. The use of AshTest…
-
Optimization and robustness of blood tests for liver fibrosis and cirrhosis.
### Objectives To optimize the performance and feasibility of fibrosis blood tests and…
-
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
…and Transient Elastography (TE) have been validated as non-invasive markers of…
-
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes.
…liver index score, non-alcoholic fatty liver disease fibrosis score, and SteatoTest…
-
The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests.
…Mean fibrosis, as measured by SWE liver stiffness and FibroTest™, did not…
-
Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?
-
Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?
-
Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.
…of hepatic fibrosis and did not predict cirrhosis. ### Conclusions Abnormal biomarkers of…
-
Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.
…of advanced fibrosis (EFT-F2) and one for the diagnosis of cirrhosis…
-
FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis. Meta Analysis
…heterogenous meta-analysis for liver fibrosis and cirrhosis, respectively. The area under…
-
Combination of fibrosis tests: sequential or synchronous?
-
Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.
-
Applicability and variability of liver stiffness measurements according to probe position.
### Aim To investigate the liver stiffness measurement (LSM) applicability and variability with…
-
FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B.
### Background Noninvasive markers of liver fibrosis have not been extensively studied in…
-
Non-invasive evaluation of the liver disease severity in children with chronic viral hepatitis using FibroTest and ActiTest - comparison with histopathological assessment.
…Further studies on non-invasive methods to evaluate liver disease severity in…
-
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
…FT) and transient elastography (TE) as markers of occurrence of cirrhosis without…
-
Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.
…of liver fibrosis received transient elastography and examinations for serum markers of…
-
Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.
…with cystic fibrosis (CF). However, detection of CF-associated liver disease (CFLD…
-
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. Key publication
…non-alcoholic fatty liver disease, NashTest, a simple and non-invasive biomarker…
-
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
…increased risk of developing liver fibrosis and liver cirrhosis. The risk increases…
-
FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
-
Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease.
…was one of the first composite liver fibrosis markers. This study aims…
-
Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
…coefficient (ADC) of water, for the diagnosis of liver fibrosis in patients…
-
Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference. Key publication
-
Transient elastography alone and in combination with FibroTest® for the diagnosis of hepatic fibrosis in alcoholic liver disease.
…of TE for liver fibrosis in patients with excessive alcohol consumption and…
-
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Key publication
…of fibrosis markers should be standardized according to the prevalence of fibrosis…
-
Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia.
…value of non-invasive biomarkers of liver fibrosis (FibroTest) and steatosis (SteatoTest…
-
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus.
…Non-invasive panels for the diagnosis of steatosis, NASH and/or fibrosis…
-
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C.
…and improve the reliable diagnosis rates of blood tests for significant liver…
-
Effective use of FibroTest to generate decision trees in hepatitis C.
…fibrosis scores in clinical studies and improve our understanding of fibrosis progression.
-
Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis.
…fibrosis, remodeling, apoptosis, and cholestasis. As a consequence, portal hypertension, cirrhosis, and…
-
The risk of multiplying diagnostic combinations in the absence of a perfect gold standard for a fibrosis test.
-
[Biomarkers for liver fibrosis: advances, advantages and disadvantages]. Review
…determining non-invasive markers for the diagnosis of liver fibrosis, since at…
-
Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.
…liver fibrosis. We investigated the prognostic role of the combined use of…
-
Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.
…the diagnosis of advanced fibrosis and cirrhosis in chronic liver disease. However…
-
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients.
…fibrosis (≥ F3) and 0.96 for cirrhosis. Using a cut-off of…
-
Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes.
…diagnostic role of ActiTest and NashTest 2 in liver fibrosis in the…
-
EASL clinical practical guidelines: management of alcoholic liver disease.
-
Letter: APRI and FIB-4 do not correlate with Fibrosure in the evaluation of liver fibrosis in hepatitis C patients.
-
Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Key publication
…A total of 218 consecutive patients with ALD and available liver biopsy…
-
Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis.
…of biopsy analysis for intermediate-stage fibrosis and inappropriate determination of the…
-
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Key publication
…to assess fibrosis. However, liver biopsy being invasive and, in many instances…
-
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
…Our aim was to determine the prevalence of liver fibrosis and associated…
-
The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
…liver stiffness, and this result is an indirect measure of hepatic fibrosis…
-
Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.
…infection and correlated these levels with the degree of liver fibrosis as…
-
Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis.
…accuracy for the assessment of liver fibrosis and was superior to other…
-
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. Review
…form of the disease, and increases the risk of cirrhosis and hepatocellular…
-
HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.
…Liver fibrosis was estimated by Fibroscan^®^ and Fibrotest^®^ . Liver-related and non…
-
Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.
…of significant fibrosis (SAFE or BA for Metavir F ≥ 2) or cirrhosis…
-
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease. Key publication
…of HCC in patients with chronic liver disease including those without cirrhosis…
-
[The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B].
…Histological staging of liver fibrosis, assessed blindly and independently by 2 pathologists…
-
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age.
…validated biomarker of fibrosis. To assess the applicability rate and to reduce…
-
Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.
…Here, we aimed to identify predictors of discordance between FT and liver…
-
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications.
### Background & Aims Noninvasive tests (NITs) of liver fibrosis have been suggested to…
-
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
…and fibrosis can be evaluated simultaneously, enlarging the spectrum of non-invasive…
-
The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.
-
Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients.
…children and adults. FibroTest results were suggestive of fibrosis regardless of time…
-
PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.
…liver fat content (LFC) and liver fibrosis independent of visceral adiposity and…
-
A novel panel of blood markers to assess the degree of liver fibrosis.
…In conclusion, the pathological staging and area of liver fibrosis can be…
-
Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus.
…non-invasive methods in screening, in assessing viral disease and liver fibrosis…
-
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
…5 non-specific and 2 specific blood tests for liver fibrosis in…
-
Biomarkers for liver disease in urea cycle disorders.
…potential utility of several non-invasive biomarkers for liver fibrosis in UCDs…
-
Prognostic value of liver fibrosis biomarkers: a meta-analysis.
…the diagnosis of fibrosis in patients with chronic liver disease. This paper…
-
Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection
…non-invasive diagnostic tests to assess the stage of liver disease and…
-
EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
-
Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.
…to assess liver fibrosis in chronic hepatitis C (CHC) and is required…
-
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.
…of reduced fibrosis progression and improved activity score. The safety profile of…
-
Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard.
…diagnosis of fibrosis as compared with FibroTest (FT) and liver stiffness measurement…
-
Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B.
…However, the sensitivity, specificity and diagnostic accuracy in evaluating liver fibrosis of…
-
Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.
…AshTest is an appropriate non-invasive alternative to transjugular liver biopsy.
-
Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.
…AUROCs for diagnosis of F> or =3 in HCV patients and non…
-
Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis.
…be promising non-invasive methods for detection of liver-fibrosis in patients…
-
Acoustic Radiation Force Impulse Imaging for Diagnosis and Monitoring of Liver Fibrosis in Patients with Hepatitis C: A Review of Diagnostic Accuracy, Clinical Effectiveness, Cost-Effectiveness, and Guidelines Review
…and cost-effectiveness evidence of diagnosis and monitoring of liver fibrosis among…
-
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.
-
Peta V, Ziol M, Imbert-Bismut F, et al., for the FibroFrance-GHPS-HECAM group
-
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
…The combined use of FibroScan and FibroTest to evaluate liver fibrosis could…
-
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Review
…fibrosis and cirrhosis. ### Methods The accuracy for severe fibrosis or cirrhosis of…
-
Commentary: prognostication of chronic hepatitis B - are Fibrotest and Fibroscan the final answers? Authors' reply.
-
Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society.
-
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
…fatty liver index (FLI) and an algorithm of nine serum markers (Fibromax…
-
Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.
…Routine assessment of liver fibrosis was requested by the surveyed physicians mostly…
-
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
…and fibrosis stages as assessed by noninvasive markers, with the occurrence of…
-
Management of the patient with SVR. Review
…reductions in rates of liver complications, hepatocellular carcinoma and mortality. Additional benefits…
-
Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
…the diagnosis of significant fibrosis (F2-F4) and cirrhosis (F4) by the…
-
Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis. Key publication
### Background No prospective diagnostic studies have directly compared widespread non-invasive liver…
-
Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
…The prevalence of fibrosis≥F2 was 10% (CHB), 42% (CHC) and 21…
-
[SWE elastography in assessment of liver fibrosis]. Review
…assessment of liver fibrosis. However, due to its invasiveness and possible complications…
-
Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
…of noninvasive markers of fibrosis in patients with chronic alcoholic liver disease…
-
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis. Key publication
…of primary liver cancer in patients without cirrhosis. ### Aim To construct and…
-
Non-invasive assessment of liver fibrosis: are we ready?
-
Spleen stiffness measurement by transient elastography to diagnose portal hypertension in children.
…with established markers of liver fibrosis and parameters of portal hypertension. ### Methods…
-
Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.
…activity and fibrosis as compared with the histological analysis of liver biopsy…
-
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.
…and FibroTest for the noninvasive assessment of liver fibrosis. ### Materials And Methods…
-
Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
…diagnosis of cirrhosis in children with chronic liver diseases. ### Patients And Methods…
-
Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.
…and the association of this parameter with insulin resistance (IR) and liver…
-
Performance of the FibroTest cannot be accurately estimated in nine paediatric patients with advanced fibrosis.
-
Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up.
…of HBV-G on liver fibrosis progression, as assessed by a non…
-
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
…the non-invasive diagnosis of liver fibrosis in NAFLD. LSM and FibroMeter…
-
HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C.
…of the IL28B CC, HCV genotype and viral load. ### Conclusion Fibrosis stage…
-
Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis.
### Background And Aims Markers predicting complications of post-hepatitis C cirrhosis are…
-
Toward non-invasive assessment strategies in autoimmune hepatitis.
…of standardized scoring for non-invasive testing, and the presence of inflammation…
-
Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.
…for fibrosis and the other for cirrhosis, optimises assessment of liver-prognosis.
-
Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication
…obesity, and liver fibrosis (resmetirom) announce the widespread use of fibrosis tests…
-
Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
…of fibrosis (nil-mild, moderate, advanced/cirrhosis), using histology as reference, and…
-
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).
…These consisted of 29 healthy volunteers and 35 patients with chronic liver…
-
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Key publication
### Background The FibroTest and ActiTest are noninvasive biochemical markers of liver injury…
-
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
…All subjects underwent anthropometric measurements and fasting blood tests. Evaluation of liver…
-
Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings.
…and biochemical responses, liver fibrosis by FibroTest, and the development of drug…
-
Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.
…and severity of liver injury. ### Conclusion A number of non-invasive markers…
-
Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.
…and METAVIR A grades, explained the false positivity of liver fibrosis staging…
-
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.
…NASH) and liver fibrosis. Patients underwent an objective assessment of COPD comorbidities…
-
Study of FibroTest and hyaluronic acid biological variation in healthy volunteers and comparison of serum hyaluronic acid biological variation between chronic liver diseases of different etiology and fibrotic stage using confidence intervals.
…F2 and F3 liver fibrosis stages in non-alcoholic fatty liver disease…
-
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease. Key publication
…the stage of fibrosis in non-alcoholic fatty liver disease (NAFLD) with…
-
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.
…identification of patients with severe fibrosis (F3-F4) and cirrhosis with an…
-
FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.
-
Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis.
…However, not all correlations observed between noninvasive markers and fibrosis stage at…
-
Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.
…The current 'gold standard' for liver cirrhosis detection is an invasive, costly…
-
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes. Key publication
…non-invasive diagnosis of the stages of fibrosis, and the grades of…
-
Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.
…Az of ARFI for cirrhosis and severe fibrosis = 0.92 and 0…
-
Study on noninvasive laboratory tests for fibrosis in chronic HBV infection and their evaluation.
…The logistic regression equations for diagnosing liver fibrosis and early cirrhosis were…
-
FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?
…These include FibroTest (BioPredictive) for the quantitative assessment of fibrosis, and ActiTest…
-
Evaluation of liver stiffness measurement by fibroscan as compared to liver biopsy for assessment of hepatic fibrosis in children with chronic hepatitis C.
…of activity and progression of the chronic liver disease including METAVIER fibrosis…
-
Poynard T, Imbert-Bismut F, Ratziu V, Myers RP, Di Martino V, Thabut D, Moussalli J, Benhamou Y
-
Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.
…and 14.1 ± 7.6 years, respectively. Features suggestive of hepatic fibrosis…
-
Impact of steatosis and inflammation definitions on the performance of NASH tests.
…limitations of similar European (Fatty Liver Inhibition of Progression) and USA (Clinical…
-
Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
…a liver biopsy and serum tested for markers of fibrosis. The discriminative…
-
[Prognosis assessment of alcoholic liver disease: how and why?]. Review
…A validation of non-invasive methods for ALD could allow a large…
-
Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease. Key publication
…fibrosis and cirrhosis and to determine whether combinations of fibrosis markers increase…
-
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Key publication
### Background FibroTest, a noninvasive method of measuring biomarkers of liver fibrosis, is…
-
Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
…stage liver fibrosis. Specific noninvasive tools and possibly combination of markers should…
-
Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
…Diagnosis of patients with severe liver fibrosis (F3/F4) by FT and…
-
Predicting significant fibrosis in hepatitis C patients in Luxembourg using serological markers.
…number of biological markers putatively associated with liver fibrosis. Fibrotest and Forns…
-
Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
…chronic liver diseases, level of fibrosis predicts liver-related complications and survival…
-
Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
…Such discordance is of little clinical consequence for liver fibrosis evaluation in…
-
Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.
…The dose-response relationship between the severity of nocturnal hypoxia and liver…
-
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.
…markers are accurate noninvasive markers of HBV-related activity and fibrosis, respectively.
-
Analytical variability of the Fibrotest proteins.
…underwent liver biopsy. We compared measurements of haptoglobin, apolipoprotein A1 and alpha2…
-
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
…utility of noninvasive markers of fibrosis (FibroTest), steatosis (SteatoTest), and steatohepatitis (NashTest…
-
A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease.
…Biochemical markers for liver fibrosis (FibroTest) and necroinflammatory features (ActiTest) are an…
-
Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.
…Liver Fibrosis (ELF) test, 0.82 (0.76-0.87); and SWE…
-
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.
…markers that accurately follow changes in fibrosis may provide alternatives to liver…
-
Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus.
…of significant fibrosis by comparison with liver biopsy was 71%, and an…
-
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. Review
…and treatment. Assessments of histologic damage typically are performed using liver biopsy…
-
An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Key publication
…medical and economic burden in Canada, affecting nearly 1% of the population…
-
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.
…of fibrosis and activity could be used as surrogate markers for liver…
-
Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.
…infection and may be a major determinant of progression of liver injury…
-
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
…liver fibrosis. However, the performance of noninvasive clinical models/scores and plasma…
-
American Association for the Study of the Liver
-
Noninvasive Testing for Nonalcoholic Steatohepatitis and Hepatic Fibrosis in Patients With Psoriasis Receiving Long-term Methotrexate Sodium Therapy.
…noninvasive monitoring of the development and progression of hepatic fibrosis in patients…
-
Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication
…WHO) and complement existing guidance on the prevention of transmission of bloodborne…
-
Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis. Review
### Background Liver fibrosis is a sign of advanced liver disease and is…
-
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab.
…severe HCV liver fibrosis and vasculitis. No beneficial effects of RTX were…
-
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. Key publication
…of the assessment of weight and height and in case of Gilbert…
-
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference. Key publication
…than those of ActiTest, FIB4, BARD, and nonalcoholic fatty liver disease scores…
-
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.
…The association between total testosterone and risk of advanced hepatic fibrosis (F3…
-
Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
…of this study was to evaluate the evolution of liver fibrosis and…
-
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
…The impact of parameter analytical variability on Fibrotest and Actitest results was…
-
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19. Key publication
…ApoA1), and haptoglobin are associated with the risk of liver fibrosis, inflammation…
-
Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.
…347) and, prospectively, in a subcohort of patients without fatty liver at…
-
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes. Key publication
…controls matched on gender, age, fibrosis stages and obesity, and taking into…
-
Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
…corresponding to fibrosis stage ≥ 2. Liver stiffness values and Fibrotest^®^ scores correlated…
-
Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.
…mean value of 40%. All children showed significant liver fibrosis (F3 [n…
-
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.
-
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection.
…The primary prognostic endpoint was the age-and sex-adjusted risk of…
Mostrando la lista completa de resultados. La página se renderiza en el servidor y no está paginada.